1. Home
  2. SNGX vs GPUS Comparison

SNGX vs GPUS Comparison

Compare SNGX & GPUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • GPUS
  • Stock Information
  • Founded
  • SNGX 1987
  • GPUS 1969
  • Country
  • SNGX United States
  • GPUS United States
  • Employees
  • SNGX N/A
  • GPUS N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • GPUS
  • Sector
  • SNGX Health Care
  • GPUS
  • Exchange
  • SNGX Nasdaq
  • GPUS NYSE
  • Market Cap
  • SNGX 7.4M
  • GPUS 7.6M
  • IPO Year
  • SNGX 1987
  • GPUS 1996
  • Fundamental
  • Price
  • SNGX $2.35
  • GPUS $3.80
  • Analyst Decision
  • SNGX
  • GPUS
  • Analyst Count
  • SNGX 0
  • GPUS 0
  • Target Price
  • SNGX N/A
  • GPUS N/A
  • AVG Volume (30 Days)
  • SNGX 621.7K
  • GPUS 79.7K
  • Earning Date
  • SNGX 03-14-2025
  • GPUS 11-19-2024
  • Dividend Yield
  • SNGX N/A
  • GPUS N/A
  • EPS Growth
  • SNGX N/A
  • GPUS N/A
  • EPS
  • SNGX N/A
  • GPUS N/A
  • Revenue
  • SNGX $364,183.00
  • GPUS $139,425,000.00
  • Revenue This Year
  • SNGX N/A
  • GPUS N/A
  • Revenue Next Year
  • SNGX $76.64
  • GPUS N/A
  • P/E Ratio
  • SNGX N/A
  • GPUS N/A
  • Revenue Growth
  • SNGX N/A
  • GPUS 3.50
  • 52 Week Low
  • SNGX $1.83
  • GPUS $3.09
  • 52 Week High
  • SNGX $14.88
  • GPUS $35.89
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 38.58
  • GPUS N/A
  • Support Level
  • SNGX $2.16
  • GPUS N/A
  • Resistance Level
  • SNGX $2.63
  • GPUS N/A
  • Average True Range (ATR)
  • SNGX 0.17
  • GPUS 0.00
  • MACD
  • SNGX 0.01
  • GPUS 0.00
  • Stochastic Oscillator
  • SNGX 36.54
  • GPUS 0.00

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About GPUS HYPERSCALE DATA INC

Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has eight reportable segments: Energy and Infrastructure; Technology and Finance; SMC; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Disruptive.

Share on Social Networks: